Firefly Neuroscience (AIFF) Consolidated Net Income (2010 - 2026)

Firefly Neuroscience's Consolidated Net Income history runs 16 years deep, the most recent figure standing at -$2.0 million for Q1 2026.

• On a quarterly basis, Consolidated Net Income rose 84.5% year-over-year to -$2.0 million in Q1 2026; TTM through Mar 2026 was -$4.8 million, a 75.63% increase from a year earlier, with the FY2025 full-year figure at -$15.7 million, down 50.12% from the prior year.
• Consolidated Net Income fell to -$2.0 million in Q1 2026 per AIFF's latest filing, from $1.7 million in the prior quarter.
• Across five years, Consolidated Net Income topped out at $1.7 million in Q4 2025 and bottomed at -$12.9 million in Q1 2025.
• The 5-year median for Consolidated Net Income is -$2.0 million (2026), against an average of -$3.2 million.
• Biggest YoY gain for Consolidated Net Income was 818.63% in 2022; the steepest drop was 3595.45% in 2022.
• Year by year, Consolidated Net Income stood at -$8.4 million in 2022, then surged by 101.2% to $100615.0 in 2023, then sank by 6734.2% to -$6.7 million in 2024, then soared by 125.45% to $1.7 million in 2025, then slumped by 217.95% to -$2.0 million in 2026.
• Per Business Quant, the three latest AIFF Consolidated Net Income figures stand at -$2.0 million (Q1 2026), $1.7 million (Q4 2025), and -$2.6 million (Q3 2025).